MA08.04 LIPI and outcomes of durvalumab as consolidation therapy after ChRT in patients with locally-advanced NSCLC

Autor:	M. Tagliamento, Sara Pilotto, R. Lobefaro, A. De Giglio, David Planchard, Gilberto Lopes, Benjamin Besse, E. Mussat, Joaquim Bosch-Barrera, C. Le Pechoux, Margarita Majem, X. Mielgo, Jessica Menis, Angela Botticella, R. López-Castro, Mariona Riudavets, C. Naltet, Frank Aboubakar, N. Dempsey, Matthias Scheffler, A. Amores, Santiago Ponce, Marc Campayo, Ernest Nadal, J. Mosquera, Roxana Reyes, Edouard Auclin, Rosario García-Campelo, Diego Signorelli, Pernelle Lavaud, M. Mosteiro, Boris Duchemann, Jose Carlos Benitez, Laura Mezquita
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Consolidation therapy Oncology medicine.medical_specialty Durvalumab business.industry Internal medicine Locally advanced Medicine In patient business
Zdroj:	Journal of Thoracic Oncology. 16:S161
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2021.01.191
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::22f44c9b05239819c140d9390b78ab6c https://doi.org/10.1016/j.jtho.2021.01.191 Zobrazit plný text záznamu